<DOC>
	<DOCNO>NCT03030950</DOCNO>
	<brief_summary>This study design explore effect peri-neural dexmedetomidine duration motor spar potential adductor canal block adult patient undergo arthroscopic medical meniscectomy set multimodal analgesia . The investigator ultimate goal increase postoperative analgesic time preserve quadriceps muscle strength promote safe early ambulation .</brief_summary>
	<brief_title>Perineural Dexmedetomidine Adductor Canal Block</brief_title>
	<detailed_description>Peripheral nerve block use long-acting local anesthetic commonly utilized sole anesthetic technique adjuvant general anesthesia post-operative pain management . However , duration sensory block single dose long act local anesthetic consistently sufficient avoid use postoperative opioids . Many adjuvant add local anesthetic augment potency prolong duration peripheral nerve block . Alpha-2 adrenoceptor agonist clonidine show increase duration peripheral nerve block . Dexmedetomidine potent selective Î±-2-adrenoceptor compare clonidine . Peri-neural dexmedetomidine evaluate animal study prolong duration sensory motor block local anesthetic without evidence neurotoxicity 14 day initial administration . The effectiveness perineural dexmedetomidine augment duration sensory block upper limb extremity block base good quality clinical evidence . Arthroscopic knee surgery associate severe postoperative pain could adequately manage femoral nerve block . However femoral nerve block associate significant motor block decrease quadriceps muscle strength may delay ambulation increase risk fall . More recently , adductor canal block ( ACB ) emerge selective motor spar effective variant femoral nerve block . Compared baseline value , adductor canal block reduces quadriceps muscle strength 8 % , versus 49 % femoral nerve block . A recent dose find MRI study report 20 ml local anesthetic closest volume ED95 adductor canal block minimal proximal spread estimate success probability 95.1 % ( 95 % credibility interval : 91-98 % ) .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Adult patient age ( 1845 ) , ASA physical status I II undergo arthroscopic medial meniscectomy . Body mass index great 35 kg/m2 . Pregnancy . Unstable coronary artery disease , congestive heart failure , arrhythmia . Baseline heart rate ( HR ) less 60 beats/min baseline systolic blood pressure le 100 mmHg . Preexisting neurological deficit neuropathy . Significant psychiatric cognitive condition interfere consent assessment . Significant renal hepatic impairment ; Severe bronchopulmonary disease , include chronic obstructive pulmonary disease obstructive sleep apnea . Known contraindication peripheral nerve block , include local skin infection , bleed diathesis , coagulopathy . Allergies local anesthetic , dexmedetomidine , component multimodal analgesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>